Michael Harper Butts, RPH is a
Pharmacist based in Clarendon, Texas. Michael Harper Butts is licensed to practice in Texas (license number 21311) and his current practice location is
Hwy 287 West, Clarendon, Texas. He can be reached at his office (for appointments etc.) via phone at
(806) 874-3554.
NPI number for Michael Harper Butts is 1598926628 and his current mailing address is Po Box 1030, Clarendon, Texas. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1598926628.
Healthcare Provider's Profile
| Full Name | Michael Harper Butts |
|---|
| Gender | Male |
|---|
| Speciality | Pharmacist |
|---|
| Location | Hwy 287 West, Clarendon, Texas |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
|---|
NPI Data:
- NPI Number: 1598926628
- Provider Enumeration Date: 06/20/2008
- Last Update Date: 06/20/2008
Medical Identifiers
Medical identifiers for Michael Harper Butts such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
|---|
| 1598926628 | NPI | - | NPPES |
| 1598890709 | Other | | NPI |
| 142479 | Medicaid | TX | |
| 4550554 | Other | | NCPDP |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
|---|
| 183500000X | Pharmacist | 21311 (Texas) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Michael Harper Butts is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
|---|
Michael Harper Butts, RPH
Po Box 1030,
Clarendon, TX 79226-1030
Ph: (806) 874-3554 | Michael Harper Butts, RPH
Hwy 287 West,
Clarendon, TX 79226-1030
Ph: (806) 874-3554 |
Reviews and Comments